PapersFlow Research Brief
Pharmacological Effects of Medicinal Plants
Research Guide
What is Pharmacological Effects of Medicinal Plants?
Pharmacological effects of medicinal plants refer to the therapeutic actions of bioactive compounds from plants such as curcumin from turmeric, boswellic acids, and guggulsterone, which exhibit anti-inflammatory, antioxidant, antiproliferative, and antiangiogenic properties in treating inflammation, cancer, osteoarthritis, and chronic diseases.
Research on pharmacological effects of medicinal plants encompasses 25,233 works focused on compounds like curcumin, boswellic acids, and guggulsterone for inflammation, cholesterol management, cancer, and osteoarthritis. Curcumin demonstrates diverse effects including anti-inflammatory and antioxidant activities, with Phase I trials confirming safety at doses up to 12 g/day in humans (Anand et al., 2007, "Bioavailability of Curcumin: Problems and Promises"). Studies highlight mechanisms of action and traditional uses, building from ancient medicine to clinical applications (Aggarwal et al., 2007, "CURCUMIN: THE INDIAN SOLID GOLD").
Topic Hierarchy
Research Sub-Topics
Pharmacological Effects of Boswellic Acids
This sub-topic examines the anti-inflammatory, analgesic, and anti-cancer mechanisms of boswellic acids derived from Boswellia serrata, including their inhibition of 5-lipoxygenase and NF-κB pathways. Researchers investigate clinical efficacy in osteoarthritis, asthma, and inflammatory bowel disease through in vitro, in vivo, and human trials.
Guggulsterone Cholesterol-Lowering Mechanisms
This area explores how guggulsterone from Commiphora mukul regulates lipid metabolism via FXR antagonism, SREBP inhibition, and LDL receptor upregulation. Studies focus on its hypolipidemic effects, pharmacokinetics, and potential in atherosclerosis prevention.
Curcumin Bioavailability Enhancement Strategies
Researchers develop formulations like nanoparticles, liposomes, and piperine co-administration to overcome curcumin's poor absorption and rapid metabolism. This sub-topic covers pharmacokinetic studies, clinical bioavailability trials, and structure-activity relationships for improved systemic delivery.
Medicinal Plant Compounds in Cancer Apoptosis
This sub-topic investigates how boswellic acids, guggulsterone, and curcumin induce apoptosis in cancer cells via caspase activation, Bcl-2 modulation, and TRAIL sensitization. Research spans molecular pathways, combination therapies, and tumor xenograft models.
Traditional Medicinal Plant Extracts in Osteoarthritis
Studies evaluate Boswellia and guggul extracts for cartilage protection, pain relief, and joint function improvement in osteoarthritis patients through randomized controlled trials and biomarker analyses. This includes comparisons with standard treatments like glucosamine.
Why It Matters
Pharmacological effects of medicinal plants drive treatments for chronic conditions through compounds like curcumin, which shows anti-inflammatory, antioxidant, antiproliferative, and antiangiogenic activities safe at 12 g/day in Phase I trials (Anand et al., 2007, "Bioavailability of Curcumin: Problems and Promises"). Clinical trials validate curcumin's roles against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune, and neoplastic diseases (Aggarwal and Harikumar, 2008, "Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases"; Gupta et al., 2012, "Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials"). Applications extend to cancer and osteoarthritis via apoptosis induction and cholesterol management with guggulsterone, supporting transitions from traditional remedies to modern pharmacology (Goel et al., 2007, "Curcumin as “Curecumin”: From kitchen to clinic").
Reading Guide
Where to Start
Start with "Bioavailability of Curcumin: Problems and Promises" by Anand et al. (2007) as it provides foundational pharmacologic effects, safety data from Phase I trials at 12 g/day, and introduces key challenges accessible to newcomers.
Key Papers Explained
Anand et al. (2007, "Bioavailability of Curcumin: Problems and Promises") establishes curcumin's diverse effects and trial safety, which Goel et al. (2007, "Curcumin as “Curecumin”: From kitchen to clinic") and Aggarwal et al. (2007, "CURCUMIN: THE INDIAN SOLID GOLD") extend to clinical transitions and traditional contexts. Gupta et al. (2012, "Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials") builds on these by analyzing trial outcomes, while Aggarwal and Harikumar (2008, "Potential therapeutic effects of curcumin...") details disease-specific mechanisms. Nelson et al. (2017, "The Essential Medicinal Chemistry of Curcumin") connects earlier work to chemical foundations.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes boswellic acids and guggulsterone for inflammation, cancer, and osteoarthritis beyond curcumin focus in top papers. No recent preprints or news in last 6-12 months indicate steady maturation. Frontiers involve mechanism refinements and compound synergies in chronic disease models.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Bioavailability of Curcumin: Problems and Promises | 2007 | Molecular Pharmaceutics | 5.2K | ✕ |
| 2 | Unbiased stereological estimation of the total number of neuro... | 1991 | The Anatomical Record | 3.0K | ✕ |
| 3 | Zeta potential in colloid science. Principles and applications | 1982 | Journal of Colloid and... | 2.3K | ✕ |
| 4 | Curcumin as “Curecumin”: From kitchen to clinic | 2007 | Biochemical Pharmacology | 2.2K | ✕ |
| 5 | Therapeutic Roles of Curcumin: Lessons Learned from Clinical T... | 2012 | The AAPS Journal | 2.0K | ✓ |
| 6 | Potential therapeutic effects of curcumin, the anti-inflammato... | 2008 | The International Jour... | 1.9K | ✓ |
| 7 | Curcumin: From ancient medicine to current clinical trials | 2008 | Cellular and Molecular... | 1.8K | ✕ |
| 8 | The Essential Medicinal Chemistry of Curcumin | 2017 | Journal of Medicinal C... | 1.8K | ✓ |
| 9 | Multiple biological activities of curcumin: A short review | 2006 | Life Sciences | 1.6K | ✕ |
| 10 | CURCUMIN: THE INDIAN SOLID GOLD | 2007 | Advances in experiment... | 1.6K | ✕ |
Frequently Asked Questions
What are the main pharmacological effects of curcumin from turmeric?
Curcumin exhibits anti-inflammatory, antioxidant, antiproliferative, and antiangiogenic activities (Anand et al., 2007, "Bioavailability of Curcumin: Problems and Promises"). Phase I clinical trials confirm its safety at high doses up to 12 g/day in humans. These effects stem from its polyphenolic structure in turmeric.
How does curcumin transition from traditional use to clinical applications?
Curcumin moves from ancient Indian medicine to modern trials addressing bioavailability challenges (Goel et al., 2007, "Curcumin as “Curecumin”: From kitchen to clinic"). Research documents its progression through Phase I safety data and therapeutic evaluations (Hatcher et al., 2008, "Curcumin: From ancient medicine to current clinical trials"). Traditional uses align with observed anti-inflammatory mechanisms.
What do clinical trials reveal about curcumin's therapeutic roles?
Trials demonstrate curcumin's efficacy against inflammation, cancer, and metabolic diseases (Gupta et al., 2012, "Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials"). Safety is established at high doses, with lessons on dosing and formulations. Applications include neurodegenerative and autoimmune conditions.
What mechanisms underlie curcumin's effects on chronic diseases?
Curcumin targets neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune, and neoplastic diseases via anti-inflammatory pathways (Aggarwal and Harikumar, 2008, "Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases"). It modulates multiple biological activities including apoptosis. These actions support its use in inflammation and cancer.
What is the medicinal chemistry profile of curcumin?
Curcumin constitutes up to 5% of turmeric and undergoes extensive investigation for therapeutic isolation (Nelson et al., 2017, "The Essential Medicinal Chemistry of Curcumin"). It is classified as both food and botanical drug. Research emphasizes its chemical properties for pharmacological applications.
How many papers cover pharmacological effects of medicinal plants?
The field includes 25,233 works on compounds like boswellic acids, guggulsterone, and curcumin. Focus areas are inflammation, cholesterol, cancer, and osteoarthritis. Growth data over 5 years is not available.
Open Research Questions
- ? How can bioavailability of curcumin be enhanced for clinical efficacy beyond 12 g/day doses?
- ? What specific molecular pathways link boswellic acids to osteoarthritis treatment?
- ? How do guggulsterone mechanisms improve cholesterol management in chronic disease models?
- ? Which combinations of plant compounds optimize anti-inflammatory effects without toxicity?
- ? What long-term outcomes emerge from curcumin trials in neoplastic and neurodegenerative diseases?
Recent Trends
The field maintains 25,233 papers with no specified 5-year growth rate.
Top citations center on curcumin's pharmacology (e.g., 5213 for Anand et al., 2007, "Bioavailability of Curcumin: Problems and Promises"), highlighting persistent focus on bioavailability and clinical safety.
No preprints or news in the last 6-12 months suggest stable research without major shifts.
Research Pharmacological Effects of Medicinal Plants with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Pharmacological Effects of Medicinal Plants with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers